- About Us
- Our Research
- Our People
- Our Facilities
QBRI is committed to establish state-of-the-art core facilities and acquire technology platforms that will be equipped with cutting-edge technologies to meet the needs of in-depth study of complex biological systems.
The Qatar Biomedical Research Institute's new wing in the R&D complex will offer specialized core facilities and platform technologies with trained staff whose prime function is to conduct and support high-quality state-of-the-art biomedical research within QBRI and other institutions in Qatar.
QBRI will establish and house 6 core facilities that will provide cutting-edge research resources and services, enabling cutting-edge research projects and facilitating advancement in diagnosing and treatment of human diseases. A significant portion of QBRI new wing labs advanced equipment is under order and a limited number has been delivered to its current, temporary laboratory facility. Additionally, a set of high-end instruments are under consideration for acquisition to complement and maintain technological capabilities.
These technology platforms and core facilities are instrumental for the Research and Development activities within our research community through the support of applications for external research funding and project consultation in collaborative relationships. As the health and research needs of the Qatari society and biomedical research community evolve over time, the cores and facilities will periodically evaluate the technology and resource needs of researchers in order to stimulate the growth of new scientific areas and development of novel technologies. In addition, the facilities will offer comprehensive training and fee-for-service technologies.
All facilities will be operated by dedicated personnel, and administered by Ph.D. science managers with extensive experience and proven track record in the area of development and/or application of the relevant technologies. QBRI also aims to work towards the Qatar national strategic goal of capacity building through competitive recruitment of young scientists and well-established faculty members. QBRI will stimulate career development of young international and local Qatari researchers.
This platform supports a wide range of cellular and molecular biology research, and also serves as vector viral production facility containing all necessary biosafety measures.
This core is easily distinguished as the only one of its kind in the entire region. This outstanding facility has expertise in the generation of human and non-human, primate-induced pluripotent stem cells (iPSCs) to validate karyotype and pluripotency characterization. Genome editing services and directed differentiation of iPSCs to pancreatic progenitors/beta cells and cortical neurons are also offered.
QBRI is currently looking to recruit highly-skilled individuals for a number of roles.
Inger van Steenoven, Nour K. Majbour, Nishant Vaikath, Henk W. Berendse, Wiesje M. van der Flier, Wilma D.J. van de Berg, Charlotte E. Teunissen, Afina W. Lemstra, and Omar M.A. El-Agnaf
Journal: Movement Disorders. Article DOI: 10.1002/mds.111, Article ID: MDS111, Internal Article ID: 15859369
Caroline Spasojevic, Elisabetta Marangoni, Sophie Vacher, Franck Assayag, Didier Meseure, Sophie Château-Joubert, Martine Humbert, Manale Karam, Jean Marc Ricort, Christian Auclair, Marie Regairaz and Ivan Bièche (2018).
Oncotarget. Doi: 10.18632/oncotarget.25292
Ali Abouelghar, Reem Hasnah, Ghina Taouk, Mohamad Saad and Manale Karam (2018).
In light of its mission towards capacity building within the field of Autism Spectrum Disorder (ASD) service provision, Qatar Biomedical Research Institute (QBRI) – a research institute within Hamad...
Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), today signed a memorandum of understanding (MoU) with the Shafallah Center, a non-profit center dedicated to ...
As part of its extensive, month-long Autism Awareness Campaign, QBRI participated in various events across Doha, to shed light on the importance of early detection of autism spectrum disorder (ASD) ...
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease